HC Wainwright & Co. analyst Joseph Pantginis downgrades Bionomics (NASDAQ:BNOX) from Buy to Neutral.
Jefferies Maintains Buy on NuCana, Lowers Price Target to $3
Jefferies analyst Eun Yang maintains NuCana (NASDAQ:NCNA) with a Buy and lowers the price target from $21 to $3.